Abivax

0 followers

Abivax SA is a clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer.

Industries

Headquarters

Paris, France

Employees

11-50

Links


Org chart

Marc De Garidel
Chief Executive Officer
Collapse
Hema Keshava
Senior Vice President Finance
Nadege Briancon-Eris
Senior Vice President, Program Management
Christine Cook
Executive Business Partner | Head Of Administration US
David Zhang
Chief Strategy Officer
Fabio Cataldi
EVP And Chief Medical Officer
Pierre Courteille
Chief Commercial Officer & VP of Business Development
Didier Scherrer
Chief Scientific Officer
Ida Hatoum
Chief People Officer and Chief Compliance Officer

Board & advisors

Kinam Hong
Director
Corinna Zur Bonsen-Thomas
Member Board Of Directors, Interim Chairman 08/2022 - 05/2023,
Ian McGowan
Chairman of the Scientific Advisory Board
Christian Bréchot
Scientific Advisor
Christoph Huber
Scientific Advisor
Jürgen Rockstroh
Scientific Advisor
Lawrence R. Stanberry
Scientific Advisor
Christian Trépo
Scientific Advisor
Luc Teyton
Scientific Advisor
Troy Ignelzi
Director
June Lee
Director